| A global Familial Hypercholesterolemia (FH) data Sharing Collaboration with European Atherosclerosis Society Familial Hypercholesterolemia Studies Collaboration (EAS FHSC) Registry | Dr Tester Framroze Ashavaid, Consultant Biochemist, P D Hinduja National Hospital & Medical Research Centre (PDHNH&MRC), Maharashtra | 2019 | European Atherosclerosis Society-Familial Hypercholesterolaemia Studies Collaboration (EAS-FHSC), Sweden | Life Sciences & Biotechnology, Medical Sciences |
| A Cluster randomised trial in Madhya Pradesh India: Community health promotion and medical provision and impact on neonates (CHAMPION 2); and support to rural Indias public education system and impact on numeracy and literacy scores (STRIPES 2) | Dr Padmanabh M Reddy, CEO, NICE Foundation, Telangana | 2019 | Effective Intervention (EI), UK | Life Sciences & Biotechnology, Medical Sciences |
| Prevention of maternal and neonatal death/infections with a single oral dose of azithromycin in women in labor (in low- and middle-income countries): a randomized controlled trial: The A PLUS Study | Dr Shivaprasad Sadashivappa Goudar, Professor, Jawaharlal Nehru Medical College (JNMC), Karnataka | 2019 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), USA, The Bill & Melinda Gates Foundation (BMGF), USA | Life Sciences & Biotechnology, Medical Sciences |
| Evaluation of the Extension for Community Healthcare Outcomes (ECHO) Clinics for Drug Resistant Tuberculosis / HIV-TB management in India | Dr Srikanth Prasad Tripathy, Scientist, National Institute for Research in Tuberculosis (ICMR-NIRT), Tamil Nadu | 2019 | ECHO Institute University of New Mexico's
Health Science Center (UNM-HSC), USA | Life Sciences & Biotechnology, Medical Sciences |
| Epidemiology and determinants of outcomes of Hospital Acquired Blood Stream Infections (HA-BSI) in the Intensive Care (EUROBACT II Study) | Dr Mohan Gurjar, Professor, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGI), Uttar Pradesh | 2019 | European Society of Intensive Care Medicine (ESICM), Belgium | Life Sciences & Biotechnology, Medical Sciences |
| Multicentre trial to assess the performance of centralized assay solutions for detection of MTB and resistance to Rifampin and Isoniazid Evaluation of Centralised TB Assay Solutions (Phase 2) Protocol Version Number: v3.0 | Dr Sanghamitra Pati, Director, Regional Medical Research Centre (ICMR-RMRC), Orissa | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Life Sciences & Biotechnology, Medical Sciences |
| Phase-II Multicentric Clinical Study to Assess the Performance of the Xpert MTB/XDR Assay for INH and Second-Line Resistance Detection ? Xpert MTB/XDR Clinical Evaluation | Dr Vithal Prasad Myneedu, Microbiologist National Institute of Tuberculosis and Respiratory Diseases (NITRD), New Delhi | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Life Sciences & Biotechnology, Medical Sciences |
| Multicentre trial to assess the performance of centralized assay solutions for detection of MTB and resistance to Rifampicin and Isoniazid | Dr Priya Rajendran, Scientist, National Institute for Research in Tuberculosis (ICMR-NIRT),Tamil Nadu | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Life Sciences & Biotechnology, Medical Sciences |
| Impact of improved diagnostic tools, practices, training and communication on acute fever case management and antibiotic prescriptions for children, adolescents and adults presenting at outpatient facilities at Jan Swasthya Sahyog, Ganiyari, Chhattisgarh, India | Dr Gajanan Baburao Phutke, Junior Consultant, Jan Swasthya Sahyog (JSS), Chhattishgarh | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Life Sciences & Biotechnology, Medical Sciences |
| Impact of improved diagnostic tools, practices, training and communication on acute fever case management and antibiotic prescriptions for children, adolescents and adults presenting at outpatient facilities in ICMR-National Institute of Cholera and Enteric Diseases, Kolkata, India | Dr Shanta Dutta, Director and Scientist, National Institute of Cholera & Enteric Diseases (ICMR-NICED), West Bengal | 2019 | Foundation for Innovative New Diagnostics (FIND), Switzerland | Life Sciences & Biotechnology, Medical Sciences |